Cleara Biotech

Dutch biotech company developing senescence-targeting therapeutics, including senolytics and senomorphics, to treat cancer and age-related diseases. Founded in 2018 in Utrecht, Netherlands, by researchers including Peter de Keizer. Cleara’s pipeline addresses cellular senescence as a driver of inflammation, fibrosis, and tumor progression. (clearabiotech.com)...